Delivery Order SPE2DB20D1100-SPE2DB23FC2V7
Award Date 6/26/23
Potential Completion Date 6/27/23
Potential Value $4.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,002 delivery order to Amerisourcebergen Drug Corporation for 25 mg tablets of VEMLIDY. The firm fixed price order is for 30 tablets to be delivered to Conshohocken, Pennsylvania by July 25, 2023 from the date of award on July 24. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to support the Defense Logistics Agency's mission of providing critical medical materiel to the U.S. Department of Defense....
- The Defense Logistics Agency awarded a $12,838 delivery order contract to Amerisourcebergen Drug Corporation for VEMLIDY 25 MG tablets. Under this firm fixed price order, Amerisourcebergen will deliver 30 bottles of the antiviral medication to a location in Conshohocken, Pennsylvania by August 17, 2023 to support the Department of Defense's pharmaceutical needs. As a top pharmaceutical supplier, Amerisourcebergen frequently fulfills delivery orders under the Defense Logistics Agency's Prime...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,501.28 to Amerisourcebergen Drug Corporation for the supply of 4561770570 VEMLIDY 25 MG TABLETS. The contract has a period of performance from August 10, 2023 through August 11, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As a major distributor of pharmaceuticals and medical supplies to the U.S. Department of Defense, this delivery order...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $6,690.78 to Amerisourcebergen Drug Corporation for VEMLIDY 25 MG tablets. Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by August 22, 2023 in support of DLA's pharmaceutical distribution requirements. As the prime contractor, Amerisourcebergen will utilize its corporate office and distribution division capabilities. No subcontractors or set aside designations...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $6,048 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4561773698 VEMLIDY 25 MG tablets. Performance will take place in Conshohocken, Pennsylvania over one day in August 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense's supply chain needs. This delivery order is likely associated with DLA's pharmaceutical prime...
- The Defense Logistics Agency awarded a delivery order valued at $3,164.34 to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) on August 11, 2025, with a completion date of August 12, 2025. This firm fixed price delivery order represents a non-competitive award under the vendor's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,000 to Amerisourcebergen Drug Corporation to supply 4561479431 VEMLIDY 25 MG tablets. Under the contract, Amerisourcebergen will deliver 30 tablets of VEMLIDY, an antiviral medication used to treat chronic hepatitis B virus infection, to a location in Conshohocken, Pennsylvania by July 13, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a subsidiary of Amerisourcebergen...
- The Defense Logistics Agency awarded a $14,468.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VEMLIDY 25 MG tablets. Under this order, Amerisourcebergen will deliver 30 bottles of the medication to a location in Conshohocken, Pennsylvania by September 11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen likely supports DLA's stockpile of prescription drugs for military treatment facilities under the...
- The Defense Logistics Agency Troop Support Medical awarded a $2,884.84 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 25 mg tablets of VEMLIDY (tenofovir alafenamide). The contract has a period of performance from September 18-19, 2023. Amerisourcebergen will deliver the VEMLIDY tablets from its facility located in Conshohocken, Pennsylvania to fulfill the agency's requirements. No major subcontractors or set aside designations were indicated. The Defense Logistics...
- The Defense Logistics Agency awarded a $2,534.35 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VEMLIDY 25 MG tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets of the specified medication to its Conshohocken, Pennsylvania facility by July 13, 2023 to fulfill requirements under the contract. The Defense Logistics Agency routinely utilizes indefinite-delivery/indefinite-quantity contracts to procure pharmaceuticals and medical supplies in direct...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FC2V7Delivery Order
The Defense Logistics Agency awarded a $4,583 delivery order to Amerisourcebergen Drug Corporation for 25 mg tablets of VEMLIDY. The firm fixed price order is for 30 tablets to be delivered to the contractor's facility in Conshohocken, Pennsylvania by June 27, 2023. As a top pharmaceutical supplier under the DLA's Pharmaceutical Prime Vendor contract, Amerisourcebergen will provide this antiretroviral medication to support the Department of Defense's treatment of HIV/AIDS. No subcontractors or set aside designations were identified in the award information.
Generated 12/15/23, 6:18 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 6/26/23 |